Signal-transduction inhibitors in renal cell carcinoma.
Vogelzang
Nicholas J
NJ
Nevada Cancer Institute, University of Nevada School of Medicine, Las Vegas, NV, USA.
Sternberg
Cora N
CN
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D015398:Signal Transduction / Q000187:drug effects*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases